Pamabrom

Pamabrom is mild diuretic consisting of a 1:1 mixture of 2-amino-2-methyl-1-propanol and 8-bromotheophyllin . It often found in combination with aceraminophen. It works by increasing urination. Pamabrom is xanthine diuretics reduce salt and water reabsorption in the proximal tubule and increase renal blood flow, yet their diuretic effect is modest. It is indicated as over-the-counter remedies to relief fluid retention and bloating associated with menstration.


Adult Dose
Dose: 25 to 50 mg
Single Dose: 38 (37.5)
Frequency: 6 hourly
Route: oral
Instructions: Maximum 25mg every four hous can be taken or take as needed.
Neonatal
Paedriatic
Characteristics
. The Molecular Weight of Pamabrom is 348.20.
Contraindications
Pamabrom is contraindicated in conditions like Hypersensitivity to the drug.
Effects
The severe or irreversible adverse effects of Pamabrom, which give rise to further complications include Hypersensitivity reactions.The symptomatic adverse reactions produced by Pamabrom are more or less tolerable and if they become severe, they can be treated symptomatically, these include Drowsiness.
Indications
Pamabrom is primarily indicated in conditions like Edema, Menstruation Bloating, Premenstrual dysphoric disorders.
Interactions
No data regarding the interactions of Pamabrom was found.
Interfrence
Risks
Drug should not be given to Paediatrics, Pregnant Mothers, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Warnings
It is not indicated in children less then 12 years of age. Take with plenty of water. Take with caution while taking other diuretics and antihypertensive drugs.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.